Han Suk Ryu Selected Research

Han Suk Ryu Research Topics

Disease

56	Neoplasms (Cancer) 01/2022 - 06/2011
37	Breast Neoplasms (Breast Cancer) 04/2022 - 12/2014
19	Triple Negative Breast Neoplasms 01/2022 - 07/2015
8	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2012
6	Lymphatic Metastasis 08/2016 - 04/2012
5	Hepatocellular Carcinoma (Hepatoma) 11/2017 - 06/2011
4	Carcinoma (Carcinomatosis) 01/2022 - 01/2017
3	Carcinogenesis 01/2022 - 11/2017
3	Ductal Carcinoma 02/2020 - 07/2015
3	Papillary Thyroid Cancer 07/2014 - 10/2012
3	Cholangiocarcinoma 01/2014 - 07/2012
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2020
2	Pathologic Complete Response 07/2020 - 11/2016
1	Papilloma (Papillomatosis) 01/2022
1	Skin Neoplasms (Skin Cancer) 01/2020
1	Genomic Instability 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Phyllodes Tumor (Cystosarcoma Phylloides) 01/2019

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 03/2022 - 04/2012
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2015
8	Biological ProductsIBA 12/2020 - 11/2011
7	Hormones (Hormone)IBA 12/2020 - 07/2015
6	Phenobarbital (Luminal)FDA Link 05/2019 - 01/2013
5	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2014
4	Messenger RNA (mRNA)IBA 01/2022 - 01/2017
4	LigandsIBA 11/2018 - 01/2013
4	Indicators and Reagents (Reagents)IBA 08/2016 - 06/2011
4	Sirtuin 1IBA 04/2016 - 07/2015
3	Paclitaxel (Taxol)FDA LinkGeneric 03/2022 - 01/2020
3	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2022 - 01/2017
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2020
3	ProteomeIBA 01/2021 - 01/2020
3	ParaffinIBA 10/2020 - 12/2010
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 08/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 11/2015
3	Keratin-19 (Keratin 19)IBA 07/2014 - 07/2012
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2020
2	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 12/2020 - 11/2020
2	Caspase 3 (Caspase-3)IBA 12/2020 - 11/2015
2	Tyrosine (L-Tyrosine)FDA Link 11/2020 - 01/2014
2	human ERBB2 proteinIBA 10/2020 - 10/2016
2	Estrogen ReceptorsIBA 02/2020 - 08/2016
2	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2017
2	Chemokine CXCL12IBA 11/2018 - 07/2014
2	Trastuzumab (Herceptin)FDA Link 10/2016 - 12/2014
2	Galectin 3 (LGALS3)IBA 07/2014 - 01/2013
1	taxaneIBA 04/2022
1	130-nm albumin-bound paclitaxelIBA 04/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2022
1	Tamoxifen FDA LinkGeneric 03/2022
1	CollagenIBA 01/2022
1	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2022
1	CalsequestrinIBA 01/2022
1	Inosine FDA Link 01/2022
1	Adenosine (Adenocard)FDA LinkGeneric 01/2022
1	Conditioned Culture MediaIBA 12/2021
1	Gefitinib (Iressa)FDA Link 01/2021
1	palbociclibIBA 01/2021
1	ceralasertibIBA 01/2021
1	Fulvestrant (Faslodex)FDA Link 01/2021
1	ClaudinsIBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 12/2020
1	Docetaxel (Taxotere)FDA Link 12/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2020
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 12/2020
1	ArginaseIBA 12/2020
1	Tryptophan-tRNA LigaseIBA 12/2020
1	CaspasesIBA 12/2020
1	protein kinase modulatorIBA 12/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2020
1	LCL161IBA 11/2020
1	Transfer RNA (tRNA)IBA 11/2020
1	navitoclaxIBA 11/2020
1	Formaldehyde (Formol)FDA Link 10/2020
1	moesinIBA 04/2020
1	Androgen Receptors (Androgen Receptor)IBA 04/2020
1	olaparibIBA 01/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	adavosertibIBA 01/2020
1	Serine (L-Serine)FDA Link 12/2019
1	RNA Splicing FactorsIBA 12/2019
1	EnzymesIBA 12/2019
1	PlatinumIBA 12/2019
1	Protein Kinases (Protein Kinase)IBA 12/2019
1	Arginine (L-Arginine)FDA Link 12/2019
1	CytokinesIBA 01/2019
1	Chemokine ReceptorsIBA 11/2018
1	ChemokinesIBA 11/2018
1	CXCR ReceptorsIBA 11/2018
1	EphrinsIBA 10/2018

Therapy/Procedure

13	Therapeutics 01/2021 - 07/2015
8	Drug Therapy (Chemotherapy) 03/2022 - 11/2015
6	Neoadjuvant Therapy 11/2020 - 01/2016
6	Adjuvant Chemotherapy 11/2018 - 07/2012
2	Radiotherapy 01/2020 - 08/2016
2	Kidney Transplantation 10/2016 - 05/2013
2	Parathyroidectomy 10/2016 - 05/2013
2	Thyroidectomy 11/2014 - 10/2012
1	Chemoprevention 01/2020
1	Adjuvant Radiotherapy 01/2019